KDM4C and breast cancer: We show that GASC1 negativity is an independent prognostic factor of poorer breast cancer specific survival, not only overall but also in groups of patients treated with different adjuvant therapies, evidence of its prognostic as well as predictive value for women with invasive breast cancer.